Sbd

Autor: Isabel Sacco

Autor: Saulo Cavalcanti

Autor: José Cláudio Garcia Lira Neto Referências: Efficacy of Cinnamon as an Adjuvant in Reducing the Glycemic Biomarkers of Type 2 Diabetes Mellitus: A Three-Month, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. J Am Nutr Assoc. 2022 Mar-Apr;41(3):266-274.

Autor: Maristela Strufaldi • Ramos S, et al. Terapia Nutricional no Pré-Diabetes e no Diabetes Mellitus Tipo 2. Diretriz Oficial da Sociedade Brasileira de Diabetes (2022). Acesso em 28 de março de 2023. • Evert AB, et al. Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes Care. 2019 May;42(5):731-754. • Schwingshackl L, et al. A network metaanalysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol. 2018 Feb;33(2):157–70 • Toledo E, et al. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Med. 2013 Sep 19;11:207. • Salas-Salvadó J, et al. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial. Diabetes Care. 2019 May;42(5):777-788. • Delgado-Lista J, et al. Long-term second

Autor: Valéria de Cássia Sparapani Revista: Pediatr Diabetes Ref: ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes education in children and adolescents. Pediatr Diabetes. 2022 Dec;23(8):1229-1242. Link de acesso: https://www.researchgate.net/profile/JuliePelicand/publication/363677195_Chapter_6_Diabetes_education_in_children_and_adolescen ts/links/63ab2bdf03aad5368e45b734/Chapter-6-Diabetes-education-in-children-andadolescents.pdf

Autor: Carolina Rocha Betonico

Autor: Maria Eugênia Hitchon Revista: Acta Paul Enferm Ref: Attitudes towards self-care in type 2 diabetes mellitus in primary care. Acta Paul Enferm 2021; 34: eAPE001765. DOI: 10.37689/acta-ape/2021AO001765

Autor: Rodrigo Huguet

Autor: Renata Andrade Lima Revista: NEJM Ref: Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. N Engl J Med. 2022 Sep 29;387(13):1161-1172. doi: 10.1056/NEJMoa2205225.

Autor: Fernando Malerbi Revista: Diabetes Care Ref: TODAY Study Group. Development and Progression of Diabetic Retinopathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study. Diabetes Care. 2021 Sep 16;45(5):1049–55. doi: 10.2337/dc21-1072.

Autor: Claudia Pieper Revista: Clin Child Psychol Psychiatry Ref: A review of risk factors associated with insulin omission for weight loss in type 1 diabetes. Clin Child Psychol Psychiatry. 2021 Jul;26(3):606-616. doi: 10.1177/13591045211026142.

Autor: Rodrigo Huguet Revista: Curr Diab Rep. Ref: Eating Disorders and Diabetes. Curr Diab Rep. 2020 Jun 15;20(8):32. doi: 10.1007/s11892-020-01320-0.

Autor: Augusto Cézar Santomauro Júnior

Autor: Juliana de Paula Peixoto Revista: Diabetologia Ref: 'Exercise snacks' before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance. Diabetologia. 2014 Jul;57(7):1437-45. doi: 10.1007/s00125-014-3244-6.

Autor: Paulo Rizzo Genestreti Revista: J Am Coll Cardiol Ref: Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 May 24;79(20):2058-2068. doi: 10.1016/j.jacc.2022.03.353.

Autor: Jonas Gordilho Souza Revista: Diabetes Care Ref: American Diabetes Association Professional Practice Committee. 13. Older Adults: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Suppl 1):S195-S207. doi: 10.2337/dc22-S013.

Autor: Mark Barone Ref: - Poster ADA: https://diatribe.org/sites/default/files/ADA%202022%20poster_Person-first%20language%20in%20scientific%20publications_FINAL%20%281%29.pdf?fbclid=IwAR1gUGymNVy8FNEMn_bTvaqji4t956_9lbIYa1db_KTkugeDzfcSD99iy5k - Guia de atualização de linguagem para diabetes, obesidade e outras condições crônicas não transmissíveis: https://www.forumdcnts.org/post/linguagem-importa

Autor: Emerson Cestari Marino Revista: Lancet Diabetes Endocrinol, Nat Med Ref: 1) Pasquel FJ. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-188. 2) Kosiborod MN. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021 Sep;9(9):586-594. 3) Voors AA. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med. 2022 Mar;28(3):568-574.

Autor: Sherida Paz Revista: J Family Med Prim Care Ref: Chowdhury S, Chakraborty PP. Errors of insulin therapy: Real-life experiences from developing world. J Family Med Prim Care 2017;6:724-9.

Autor: Claudia Pieper